Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION

ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION in Canada?

Yes. KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION 12MG has an active shortage reported to Health Canada (last updated July 29, 2026).

Why is KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION be available again?

The manufacturer's estimated resolution date is March 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Expected resolution~6 months remaining (estimate)
Affected strength12MG
Last updated2026-07-29

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-03-31

~6 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02513870

Strength

12MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

TETRASODIUM PYROPHOSPHATE

Tier

Unrated

Last Updated

2026-07-29

Reason for Shortage

Disruption of the manufacture of the drug.